Abstract
Brachytherapy is a radiation modality treatment where a radioactive source is placed inside or close to the tumor; this procedure is minimally invasive and in lung cancer is generally used for non-small cell lung cancer. The targets of brachytherapy treatment in lung cancer are diverse: we can use it with radical intention only if surgery or external beam radiotherapy cannot be realized, as an adjuvant to surgery in case of close or positive margins, as a boost to external beam radiotherapy, or with palliative intention in the case that the symptoms are related to intraluminal component of the lung cancer. Attending to the different brachytherapy techniques, we can refer to endoluminal, interstitial, or intraoperative. Technological advances in the last two decades have helped in the development of brachytherapy, but most of our knowledge is based on historical and retrospective studies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aumont-le Guilcher M, Prevost B, Sunyach MP et al (2011) High-dose-rate brachytherapy for non-small-cell lung carcinoma: a retrospective study of 226 patients. Int J Radiat Oncol Biol Phys 79:1112–1116
Aygun C, Blum JE (1995) Treatment of unresectable lung cancer with brachytherapy. World J Surg 19:823–827
Aygun C, Weiner S, Scariato A, Spearman D, Stark L (1992) Treatment of non-small cell lung cancer with external beam radiotherapy and high dose rate brachytherapy. Int J Radiat Oncol Biol Phys 23:127–132
Bedwinek J, Petty A, Bruton C, Sofield J, Lee L (1992) The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 22:23–30
Birdas TJ, Koehler RP, Colonias A et al (2006) Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer. Ann Thorac Surg 81:434–438. discussion 438–439
Brach B, Buhler C, Hayman MH, Joyner LRJ, Liprie SF (1994) Percutaneous computed tomography-guided fine needle brachytherapy of pulmonary malignancies. Chest 106:268–274
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424
Celebioglu B, Gurkan OU, Erdogan S et al (2002) High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer. Jpn J Clin Oncol 32:443–448
Chatzikonstantinou G, Zamboglou N, Baltas D et al (2019) Image-guide interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: a single institute experience. Brachytherapy 18:829–834
Chen A, Galloway M, Landreneau R et al (1999) Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys 44:1057–1063
Colonias A, Betler J, Trombetta M et al (2011) Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy. Int J Radiat Oncol Biol Phys 79:105–109
Cotter GW, Lariscy C, Ellingwood KE, Herbert D (1993) Inoperable endobronchial obstructing lung cancer treated with combined endobronchial and external beam irradiation: a dosimetric analysis. Int J Radiat Oncol Biol Phys 27:531–535
Delclos ME, Komaki R, Morice RC, Allen PK, Davis M, Garden A (1996) Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions. Radiology 201:279–282
Doggett SW, Chino S, Lempert T (2019) A novel approach for salvage treatment of non-small-cell lung cancer: Percutaneous CT fluoroscopy-guided permanent seed brachytherapy for salvage treatment of lung cancer: long-term results of a case series. J Contemp Brachyther 11:174–179
Du P, Xiao Y, Lu W (2017) Modified fan-shaped distribution technology for computed tomography (CT)-Guided radioactive seed implantation in lung cancer patients with lung dysfunction. Med Sci Monit 23:4366–4375
Ettinger DS, Gettinger S, Ng T et al (2020) NCCN Guidelines: non-small cell lung cancer, version 8.2020. National Comprehensive Cancer Network
Freitag L, Ernst A, Thomas M et al (2004) Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax 59:790–793
Furuta M, Tsukiyama I, Ohno T et al (1999) Radiation therapy for roentogenographically occult lung cancer by external beam irradiation and endobronchial high dose rate brachytherapy. Lung Cancer 25:183–189
Fuwa N, Ito Y, Matsumoto A, Morita K (2000) The treatment results of 40 patients with localized endobronchial cancer with external beam irradiation and intraluminal irradiation using low dose rate (192)Ir thin wires with a new catheter. Radiother Oncol 56:189–195
Gaspar LE (1998) Brachytherapy in lung cancer. J Surg Oncol 67:60–70
Gauwitz M, Ellerbroek N, Komaki R et al (1992) High dose endobronchial irradiation in recurrent bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 23:397–400
Ginsberg RJ, Martini N, Zaman M et al (1994) Influence of surgical resection and brachytherapy in the management of superior sulcus tumor. Ann Thorac Surg 57(1440–1):445
Gollins SW, Ryder WD, Burt PA, Barber PV, Stout R (1996) Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus. Radiother Oncol 39:105–116
Heelan RT, Hilaris BS, Anderson LL et al (1987) Lung tumors: percutaneous implantation of I-125 sources with CT treatment planning. Radiology 164:735–740
Hennequin C, Bleichner O, Tredaniel J et al (2007) Long-term results of endobronchial brachytherapy: a curative treatment? Int J Radiat Oncol Biol Phys 67:425–430
Henschke UK, Hilaris BS, Mahan GD (1964) Remote after loading with intracavitary applicators. Radiology 83:344–345
Hilaris BS, Martini N (1979) Interstitial brachytherapy in cancer of the lung: a 20 year experience. Int J Radiat Oncol Biol Phys 5:1951–1956
Hilaris BS, Martini N (1988) the current state of intraoperative interstitial brachytherapy in lung cancer. Int J Radiat Oncol Biol Phys 15:1347–1354
Hilaris BS, Martini N, Wong GY, Nori D (1987) Treatment of superior sulcus tumor (Pancoast tumor). Surg Clin North Am 67:965–977
Huber RM, Fischer R, Hautmann H et al (1995) Palliative endobronchial brachytherapy for central lung tumors. A prospective, randomized comparison of two fractionation schedules. Chest 107:463–470
Huber RM, Fischer R, Hautmann H, Pollinger B, Haussinger K, Wendt T (1997) Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors. Int J Radiat Oncol Biol Phys 38:533–540
Ji Z, Jiang Y, Guo F et al (2020) Safety and efficacy of CT-guided radioactive iodine-125 seed implantation assisted by a 3D printing template for the treatment of thoracic malignancies. J Cancer Res Clin Oncol 146:229–236
Jiang G, Li Z, Ding A et al (2015) Computed tomography-guided iodine-125 interstitial implantation as an alternative treatment option for lung cancer. Indian J Cancer 51:e9ee12
Jiao D, Ren K, Li Z et al (2017) Clinical role of guidance by C-arm CT for (125)I brachytherapy on pulmonary tumors. Radiol Med 122:829–836
Kelly JF, Delclos ME, Morice RC, Huaringa A, Allen PK, Komaki R (2000) High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M. D. Anderson cancer center experience. Int J Radiat Oncol Biol Phys 48:697–702
Kim JH, Hilaris B (1975) Iodine 125 source in interstitial tumor therapy. Clinical and biological considerations. Am J Roentgenol Radium Ther Nucl Med 123:163–169
Knox MC, Bece A, Bucci J et al (2018) Endobronchial brachytherapy in the management of lung malignancies: 20 years of experience in an Australian center. Brachytherapy 17:973–980
Kohek PH, Pakisch B, Glanzer H (1994) Intraluminal irradiation in the treatment of malignant airway obstruction. Eur J Surg Oncol 20:674–680
Kou F, Gao S, Liu S et al (2019) Preliminary clinical efficacy of iodine-125 seed implantation for the treatment of advanced malignant lung tumors. J Cancer Res Ther 15:1567–1573
Kubaszewska M, Skowronek J, Chichel A, Kanikowski M (2008) The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irradiated lung cancer. Neoplasma 55:239–245
Langendijk H, de Jong J, Tjwa M et al (2001) External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol 58:257–268
Lee W, Daly BD, DiPetrillo TA et al (2003) Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg 75:237–242. discussion 242–3
Lewis JW Jr, Ajlouni M, Kvale PA et al (1990) Role of brachytherapy in the management of pulmonary and mediastinal malignancies. Ann Thorac Surg 49:728–732. Discussion 732e723
Li J, Yu M, Xiao Y et al (2013) Computed tomography fluoroscopy-guided percutaneous (125)I seed implantation for safe, effective and real-time monitoring radiotherapy of inoperable stage T1-3N0M0 nonsmall-cell lung cancer. Mol Clin Oncol 1:1019–1024
Li W, Guan J, Yang L, Zheng X, Yu Y, Jiang J (2015) Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapy. Med Oncol 32:395.
Li W, Guan J, Yang L et al (2015) Iodine-125 brachytherapy improved overall survival of patients with inoperable stage III/IV non-small cell lung cancer versus the conventional radiotherapy. Med Oncol 32:395
Lo TC, Beamis JFJ, Weinstein RS et al (1992) Intraluminal low-dose rate brachytherapy for malignant endobronchial obstruction. Radiother Oncol 23:16–20
Mallick I, Sharma SC, Behera D (2007) Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer–analysis of symptom response, endoscopic improvement and quality of life. Lung Cancer 55:313–318
Marsiglia H, Baldeyrou P, Lartigau E et al (2000) High-dose-rate brachytherapy as sole modality for early-stage endobronchial carcinoma. Int J Radiat Oncol Biol Phys 47:665–672
Martinez-Monge R, Pagola M, Vivas I, Lopez-Picazo JM (2008) CT-guided permanent brachytherapy for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC). Lung Cancer 61:209–213
McKenna RJJ, Mahtabifard A, Yap J et al (2008) Wedge resection and brachytherapy for lung cancer in patients with poor pulmonary function. Ann Thorac Surg 85:S733–S736
Mehta M, Petereit D, Chosy L et al (1992) Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway occlusion. Int J Radiat Oncol Biol Phys 23:133–139
Mendiondo OA, Dillon M, Beach LJ (1983) Endobronchial brachytherapy in the treatment of recurrent bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 9:579–582
Moylan D, Strubler K, Unal A, Mohiuddin M, Giampetro A, Boon R (1983) Work in progress. Transbronchial brachytherapy of recurrent bronchogenic carcinoma: a new approach using the flexible fiberoptic bronchoscope. Radiology 147:253–254
Muto P, Ravo V, Panelli G, Liguori G, Fraioli G (2000) High-dose rate brachytherapy of bronchial cancer: treatment optimization using three schemes of therapy. Oncologist 5:209–214
Nag S, Kelly JF, Horton JL, Komaki R, Nori D (2001) Brachytherapy for carcinoma of the lung. Oncology (Williston Park) 15:371–381
Niemoeller OM, Pollinger B, Niyazi M et al (2013) Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors. Radiat Oncol 8:8
Nomoto Y, Shouji K, Toyota S et al (1997) High dose rate endobronchial brachytherapy using a new applicator. Radiother Oncol 45:33–37
Nori D, Allison R, Kaplan B, Samala E, Osian A, Karbowitz S (1993) High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results. Chest 104:1006–1011
Ornadel D, Duchesne G, Wall P, Ng A, Hetzel M (1997) Defining the roles of high dose rate endobronchial brachytherapy and laser resection for recurrent bronchial malignancy. Lung Cancer 16:203–213
Ozkok S, Karakoyun-Celik O, Goksel T et al (2008) High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients. Lung Cancer 62:326–333
Peiffert D, Spaeth D, Menard O, Winnefeld J (2000) High dose endobronchial brachytherapy: a curative treatment. Cancer Radiother 4:197–201
Perol M, Caliandro R, Pommier P et al (1997) Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Chest 111(5):1417–1423
Qiu B, Jiang P, Ji Z, Huo X, Sun H, Wang J (2020) Brachytherapy for lung cancer. Brachytherapy S1538–4721(20):30253–30251. https://doi.org/10.1016/j.brachy.2020.11.009. Epub ahead of print. PMID: 33358847
Reveiz L, Rueda JR, Cardona AF (2012) Palliative endobronchial brachytherapy for non-small cell lung cancer. Cochrane Database Syst Rev 12:CD004284
Rodrigues G, Videtic GM, Sur R (2011) Palliative thoracic radiotherapy in lung cancer: an American Society for Radiation Oncology evidence-based clinical practice guideline. Pract Radiat Oncol:60–71
Saito M, Yokoyama A, Kurita Y, Uematsu T, Tsukada H, Yamanoi T (2000) Treatment of roentgenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low-dose-rate brachytherapy: second report. Int J Radiat Oncol Biol Phys 47:673–680
Santos R, Colonias A, Parda D et al (2003) Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer. Surgery 134:691–697. discussion 697
Schraube P, Fritz P, Becker HD, Wannenmacher M (1993) The results of the endoluminal high-dose-rate irradiation of central non-small cell bronchial carcinomas. Strahlenther Onkol 169:228–234
Schray MF, McDougall JC, Martinez A, Edmundson GK, Cortese DA (1985) Management of malignant airway obstruction: clinical and dosimetric considerations using an iridium-192 afterloading technique in conjunction with the neodymium-YAG laser. Int J Radiat Oncol Biol Phys 11:403–409
Schray MF, McDougall JC, Martinez A, Cortese DA, Brutinel WM (1988) Management of malignant airway compromise with laser and low dose rate brachytherapy. The Mayo Clinic experience. Chest 93:264–269
Sider L, Mittal BB, Nemcek AAJ, Bobba VS (1988) CT-guided placement of iodine-125 seeds for unresectable carcinoma of the lung. J Comput Assist Tomogr 12:515–517
Skowronek J, Kubaszewska M, Kanikowski M, Chichel A, Mlynarczyk W (2009) HDR endobronchial brachytherapy (HDRBT) in the management of advanced lung cancer—comparison of two different dose schedules. Radiother Oncol 93:436–440
Skowronek J, Piorunek T, Kanikowski M et al (2013) Definitive high-dose-rate endobronchial brachytherapy of bronchial stump for lung cancer after surgery. Brachytherapy 12:560–566
Soror T, Kovacs G, Furschke V et al (2019) Salvage treatment with sol high-dose-rate endobronchial interventional radiotherapy (brachytherapy) for isolated endobronchial tumor recurrence in nonsmall-cell lung cancer patients: a 20-year experience. Brachytherapy 18:727–732
Speiser BL, Spratling L (1993a) Remote after loading brachytherapy for the local control of endobronchial carcinoma. Int J Radiat Oncol Biol Phys 25:579–587
Speiser BL, Spratling L (1993b) Radiation bronchitis and stenosis secondary to high dose rate endobronchial irradiation. Int J Radiat Oncol Biol Phys 25:589–597
Stewart AJ, Mutyala S, Holloway CL, Colson YL, Devlin PM (2009) Intraoperative seed placement for thoracic malignancy—a review of technique, indications, and published literature. Brachytherapy 8:63–69
Stewart A, Parashar B, Patel M et al (2016) American Brachytherapy Society consensus guidelines for thoracic brachytherapy for lung cancer. Brachytherapy 15:1–11
Stout R, Barber P, Burt P et al (2000) Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beam radiotherapy in the palliative treatment of inoperable non-small cell lung cancer. Radiother Oncol 56:323–327
Sutedja G, Baris G, van Zandwijk N, Postmus PE (1994) High-dose rate brachytherapy has a curative potential in patients with intraluminal squamous cell lung cancer. Respiration 61:167–168
Taulelle M, Chauvet B, Vincent P et al (1998) High dose rate endobronchial brachytherapy: results and complications in 189 patients. Eur Respir J 11:162–168
Tredaniel J, Hennequin C, Zalcman G et al (1994) Prolonged survival after high-dose rate endobronchial radiation for malignant airway obstruction. Chest 105:767–772
Trombetta MG, Colonias A, Makishi D et al (2008) Tolerance of the aorta using intraoperative iodine-125 interstitial brachytherapy in cancer of the lung. Brachytherapy 7:50–54
Tselis N, Ferentinos K, Kolotas C et al (2011) Computed tomography guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies. J Thorac Oncol 6:545–552
Vergnon JM, Huber RM, Moghissi K (2006) Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers. Eur Respir J 28:200–218
Voynov G, Heron DE, Lin CJ et al (2005) Intraoperative (125) I Vicryl mesh brachytherapy after sublobar resection for high-risk stage I non-small cell lung cancer. Brachytherapy 4:278–285
Wang ZM, Lu J, Liu T et al (2011) CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer. Lung Cancer 74:253–257
Wang Y, Guo JH, Zhu GY et al (2017) A novel self-expandable, radioactive airway stent loaded with (125)I seeds: a feasibility and safety study in healthy beagle dog. Cardiovasc Intervent Radiol 40:1086–1093
Wang Y, Lu J, Guo JH et al (2018) A novel tracheobronchial stent loaded with (125)I seeds in patients with malignant airway obstruction compared to a conventional stent: a prospective randomized controlled study. EBioMedicine 33:269–275
Wei W, Shen XH, Sun HH et al (2012) The short term therapeutic effects of radioactive (125)I seeds implantation for treatment of non-small cell lung cancer. Zhonghua Nei Ke Za Zhi 51:978–981
Yan WL, Lv JS, Guan ZY et al (2017) Impact of target area selection in (125) Iodine seed brachytherapy on locoregional recurrence in patients with non-small cell lung cancer. Thorac Cancer 8:147–152
Zhang F, Wang J (2019) Chinese expert consensus workshop report: guideline for permanent iodine-125 seed implantation of primary and metastatic lung tumors. Thoracic Cancer 10(2):388–394. ISSN 1759–7706
Zhang FJ, Li CX, Wu PH et al (2007) CT guided radioactive 125I seed implantation in treating localized advanced pulmonary carcinoma. Zhonghua Yi Xue Za Zhi 87:3272–3275
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
de Lucas, R.H., Miguelañez, T.M., Polo, A., Narvaez, P.L.A., Barreto, D.B. (2023). Brachytherapy for Lung Cancer. In: Jeremić, B. (eds) Advances in Radiation Oncology in Lung Cancer. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2022_325
Download citation
DOI: https://doi.org/10.1007/174_2022_325
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-34846-4
Online ISBN: 978-3-031-34847-1
eBook Packages: MedicineMedicine (R0)